Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carrimycin Treatment for COVID-19
NCT04286503Phase 4Unknown
- Sponsor
- Beijing YouAn Hospital
- Start
- Feb 2020
- Primary completion
- Feb 2021
- Modality
- Allosteric Modulators
01
Overview
A Phase 4 trial of carrimycin in coronavirus disease 2019 (COVID-19), sponsored by Beijing YouAn Hospital. Status: unknown.
02
Drugs
carrimycin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04286503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04286503.